Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 6—June 2007


Endemic Human Monkeypox, Democratic Republic of Congo, 2001–2004

Anne W. Rimoin*, Neville Kisalu†, Benoit Kebela-Ilunga‡, Thibaut Mukaba†, Linda L. Wright§, Pierre Formenty¶, Nathan D. Wolfe#, Robert Loshima Shongo‡, Florimond Tshioko**, Emile Okitolonda††, Jean-Jacques Muyembe†, Robert W. Ryder‡‡, and Hermann Meyer§§Comments to Author 
Author affiliations: *University of California, Los Angeles, California, USA; †National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo; ‡Ministry of Health, Kinshasa, Democratic Republic of Congo; §National Institutes of Health, Bethesda, Maryland, USA; ¶World Health Organization, Geneva, Switzerland; #Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; **World Health Organization, Kinshasa, Democratic Republic of Congo; ††Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo; ‡‡University of North Carolina, Chapel Hill, North Carolina, USA; §§Bundeswehr Institute of Microbiology, Munich, Germany;

Main Article

Table 1

Orthopoxviruses and varicella-zoster virus, Democratic Republic of Congo, 2001–2004*

Specimen (no. patients) MPX virus isolated PCR result
Orthopoxvirus VZV
Crusts (50) 16 18 21
Vesicle fluid (51) 19 21 24
Crusts and vesicle fluid (35) 8 and 5† 13‡ 17‡
Total (136) 48 52 62

*MPX, monkeypox; VZV, varicella-zoster virus.
†Virus was isolated from both specimens from 8 patients and from either specimen from 5 patients.
‡Both specimens were positive by PCR.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO